Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,556 across all filing types
Latest filing 2019-02-12 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a notice announcing a meeting of the Board of Directors to approve audited financial results for the year ended December 31, 2018, and to consider the recommendation of a final dividend. It provides details about the meeting date and where the notice can be accessed. The document is short (1397 characters) and does not contain the actual financial results or detailed report itself. It is an announcement related to the approval of the annual financial results and dividend recommendation, not the report itself. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about the board meeting and financial results approval, not the full Annual Report or Earnings Release.
2019-02-12 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board of Directors meeting scheduled for 26th February 2019. The purpose of the meeting includes approving audited accounts for the year ended 31st December 2018 and recommending a final dividend. This is a typical announcement of a board meeting rather than the actual report or financial statements. The document is brief (817 characters) and does not contain any financial data or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about a board meeting and not the actual Annual Report or Dividend Notice.
2019-02-11 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a partnership between the Directorate of Health Services (Government of Goa) and Sanofi India to reduce the diabetes burden in the state. It contains no financial data, regulatory filings, or corporate governance information. It is not a report, financial statement, or regulatory announcement. It is a public relations communication about a CSR initiative and health program launch. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement or miscellaneous filing that does not fit other categories.
2019-02-01 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release about a new advertising campaign for a product by Sanofi India. It discusses the creative aspects of the campaign, the product benefits, and the media strategy. There is no mention of financial data, regulatory filings, shareholder information, or any corporate governance or financial reporting content. The document is promotional and marketing-related, not a financial or regulatory filing. Given the provided filing categories, none directly match a marketing or advertising campaign announcement. The closest fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2019-01-21 English
News Clarification
Regulatory Filings Classification · 100% confidence The document text is extremely short (73 characters) and contains no substantive content, only placeholders and an omitted picture. There is no financial data, report content, or any detailed information. This is likely a placeholder or a minimal announcement without any report attached or detailed information. According to the rules, such minimal content with no report data defaults to Regulatory Filings (RNS) as a fallback category.
2018-11-13 English
Financial Result Updates
Regulatory Filings
2018-11-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.